GL1X · GenesisL1 explorer

MolNFT v1 · #145579 · protein

Crystal structure of human beta-defensin 2 in complex with PIP2

6CS9 · Beta-defensin 4A: “Crystal structure of human beta-defensin 2 in complex with PIP2”. X-ray diffraction, 1 ligand (PIO), 2 pockets (best druggability 0.36). MolNFT v1 #145579 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6CS9
Type
protein
Length
82 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-defensin 4A
UniProt
O15263
Ligands
PIO
Pockets
2 · best druggability 0.36

Structure

x-ray diffraction · 1 distinct chain · 12% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBeta-defensin 4Aprotein4112% helix, 37% strandO15263

Ligands and binding sites

  • PIO · [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2, 3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1600.360.7814empty
2540.300.7513empty

Interfaces

1 interface between chains.

  • A–B · 393 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 6CS9 · Crystal structure of human beta-defensin 2 in complex with PIP2 · the same entry in another collection · chain A against A, TM-score 1.00
  • O15263 · AlphaFold monomer V2.0 prediction for beta-defensin 4A (O15263) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.